- AU$250.13m
- AU$51.51m
- AU$5.78m
- 90
- 72
- 81
- 93
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.22 | ||
| Price to Tang. Book | 1.22 | ||
| Price to Free Cashflow | 16.63 | ||
| Price to Sales | 51.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.02% | ||
| Return on Equity | 11.45% | ||
| Operating Margin | -0.75% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 6.51 | 5.04 | 3.93 | 4.22 | 5.78 | n/a | n/a | -3.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -92.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
WAM Research Limited is an Australia-based investment company. The principal activity of the Company is making investments in listed companies. The Company’s investment objectives are to deliver a stream of fully franked dividends and to achieve a high real rate of return, comprising both income and capital growth, within the risk parameters acceptable to the directors. It provides investors with exposure to a diversified portfolio of undervalued growth companies, which are generally small-to-medium sized industrial companies listed on the Australian Securities Exchange (ASX). It invests in various sectors, such as industrials, consumer discretionary, healthcare, real estate, financials, consumer staples, communication services, materials, information technology and energy. MAM Pty Limited is the investment manager of the Company.
Directors
- Geoffrey Wilson CHM (63)
- Jesse Hamilton SEC
- Linda Kiriczenko SEC
- Katherine Thorley NED
- John Abernethy NID (60)
- Julian Gosse NID (65)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 10th, 2002
- Public Since
- August 19th, 2003
- No. of Shareholders
- 10,052
- No. of Employees
- 30
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 202,532,134
- Address
- Level 26, SYDNEY, 2000
- Web
- https://wilsonassetmanagement.com.au/lic/wam-research/
- Phone
- +61 292476755
- Auditors
- Pitcher Partners
Upcoming Events for WAX
Full Year 2024 WAM Research Ltd Earnings Release
Similar to WAX
360 Capital Mortgage Reit
Australian Stock Exchange - SEATS
360 Capital
Australian Stock Exchange - SEATS
A1 Investments & Resources
Australian Stock Exchange - SEATS
Acorn Capital Investment Fund
Australian Stock Exchange - SEATS
Alternative Investment Trust
Australian Stock Exchange - SEATS
FAQ
What is the Wam Research share price?
As of Today at 19:23 UTC, shares in Wam Research are trading at AU$1.24. This share price information is delayed by 15 minutes.
How has the Wam Research share price performed this year?
Shares in Wam Research last closed at AU$1.24 and the price had moved by over the past 365 days. In terms of relative price strength the Wam Research share price has underperformed the ASX All Ordinaries Index by -6.85% over the past year.
What are the analyst and broker recommendations for Wam Research?
There is no consensus recommendation for this security.
What is the Wam Research dividend yield?
The Wam Research dividend yield is 8.1% based on the trailing twelve month period.
Does Wam Research pay a dividend?
Last year, Wam Research paid a total dividend of AU$0.10, and it currently has a trailing dividend yield of 8.1%.Looking ahead, shares in Wam Research are due to go ex-dividend on 2024-04-19 and the next dividend pay date is 2024-04-30.
When does Wam Research next pay dividends?
Wam Research are due to go ex-dividend on 2024-04-19 and the next dividend pay date is 2024-04-30. The historic dividend yield on Wam Research shares is currently 8.1%.
How do I buy Wam Research shares?
To buy shares in Wam Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Wam Research?
As of the previous close price of AU$1.24, shares in Wam Research had a market capitalisation of AU$250.13m.
Where are Wam Research shares listed?
Here are the trading details for Wam Research:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: WAX
What kind of share is Wam Research?
Based on an overall assessment of its quality, value and momentum Wam Research is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Wam Research share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Wam Research share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wam Research. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +6.11%.
As of the last closing price of AU$1.24, shares in Wam Research were trading +13.18% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Wam Research PE Ratio?
The Wam Research PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$1.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Wam Research?
Wam Research's management team is headed by:
- Geoffrey Wilson - CHM
- Jesse Hamilton - SEC
- Linda Kiriczenko - SEC
- Katherine Thorley - NED
- John Abernethy - NID
- Julian Gosse - NID